These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15634643)

  • 1. Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment.
    Jhaveri MS; Rait AS; Chung KN; Trepel JB; Chang EH
    Mol Cancer Ther; 2004 Dec; 3(12):1505-12. PubMed ID: 15634643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels.
    Rait AS; Pirollo KF; Xiang L; Ulick D; Chang EH
    Mol Med; 2002 Aug; 8(8):475-86. PubMed ID: 12435858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining doxorubicin and liposomal anti-HER-2/NEU antisense oligodeoxynucleotides to treat HER-2/NEU-expressing MDA-MB-435 breast tumor model.
    Waterhouse DN; Gelmon KA; Masin D; Bally MB
    J Exp Ther Oncol; 2003; 3(5):261-71. PubMed ID: 14696623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC; Jiang XP; Elliott RL; Head JF
    Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells.
    Li S; Deshmukh HM; Huang L
    Pharm Res; 1998 Oct; 15(10):1540-5. PubMed ID: 9794495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
    Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
    Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
    Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
    Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line.
    Dixon KH; Trepel JB; Eng SC; Cowan KH
    Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines.
    Banu H; Sethi DK; Edgar A; Sheriff A; Rayees N; Renuka N; Faheem SM; Premkumar K; Vasanthakumar G
    J Photochem Photobiol B; 2015 Aug; 149():116-28. PubMed ID: 26057021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER-2-targeted antisense oligonucleotide results in sensitization of head and neck cancer cells to chemotherapeutic agents.
    Rait AS; Pirollo KF; Ulick D; Cullen K; Chang EH
    Ann N Y Acad Sci; 2003 Dec; 1002():78-89. PubMed ID: 14751825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
    Yang DC; Jiang X; Elliott RL; Head JF
    Anticancer Res; 2002; 22(3):1513-24. PubMed ID: 12168831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimal effects of liposome on antisense oligodeoxynucleotides uptake by mouse breast cancer TM40D cells and the effects of antisense oligodeoxynucleotides targeting c-erbB-2 on cell proliferation and apoptosis].
    Liu XA; Fan P; Wu ZY
    Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):802-5. PubMed ID: 15363300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
    Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
    Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.
    Wang S; Lee RJ; Cauchon G; Gorenstein DG; Low PS
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3318-22. PubMed ID: 7724560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles.
    Zhou W; Yuan X; Wilson A; Yang L; Mokotoff M; Pitt B; Li S
    Bioconjug Chem; 2002; 13(6):1220-5. PubMed ID: 12440856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to methotrexate in SKOV-3 cell lines after chronic exposure to carbamazepine is associated with a decreased expression of folate receptor.
    Toffoli G; Corona G; Tolusso B; Sartor F; Sorio R; Mini E; Boiocchi M
    Int J Cancer; 2000 Mar; 85(5):683-90. PubMed ID: 10699949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.